Tue Jun 28, 2022 – 8:21 pm EDTTue Jun 28, 2022 – 8:32 pm EDT
(LifeSiteNews) — Unlike the U.S. Centers for Disease Control (CDC), the U.K.’s Health Security Agency (UKHSA) is not camouflaging the fact that it is explicitly targeting homosexual men who engage in high-risk sexual activity for monkeypox vaccination in order to stem the spread of the disease.
In an advisory published last week, the UKHSA noted that ongoing transmission is occurring “primarily in gay, bisexual and other men who have sex with men (GBMSM).”
The UKHSA working in conjunction with the Joint Committee on Vaccination and Immunisation (JCVI) determined that “vaccination should be offered as soon as feasible to GBMSM at highest risk due to a large number of contacts.”
“These risk criteria would include a recent history of multiple partners, participating in group sex, attending sex on premises venues or a proxy marker such as recent bacterial STI (sexually transmitted infections).”
“According to the UKHSA, among those whose gender information was available, 99 percent of the UK’s confirmed cases identified themselves as male,” reported the Epoch Times’ Lily Zhou.
Because there is currently no vaccine licensed in the U.K. or Europe
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors